NO895027D0 - Hurtig avspaltbart substrat for hiv-protease. - Google Patents

Hurtig avspaltbart substrat for hiv-protease.

Info

Publication number
NO895027D0
NO895027D0 NO895027A NO895027A NO895027D0 NO 895027 D0 NO895027 D0 NO 895027D0 NO 895027 A NO895027 A NO 895027A NO 895027 A NO895027 A NO 895027A NO 895027 D0 NO895027 D0 NO 895027D0
Authority
NO
Norway
Prior art keywords
hiv protease
thr
playable
ile
val
Prior art date
Application number
NO895027A
Other languages
English (en)
Other versions
NO895027L (no
Inventor
Karin Moelling
Stephan Henke
Gerhard Breipohl
Wolfgang Koenig
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO895027D0 publication Critical patent/NO895027D0/no
Publication of NO895027L publication Critical patent/NO895027L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO89895027A 1988-12-15 1989-12-14 Hurtig avspaltbart substrat for hiv-protease. NO895027L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3842197A DE3842197A1 (de) 1988-12-15 1988-12-15 Rasch spaltbares substrat fuer die hiv-protease

Publications (2)

Publication Number Publication Date
NO895027D0 true NO895027D0 (no) 1989-12-14
NO895027L NO895027L (no) 1990-06-18

Family

ID=6369209

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89895027A NO895027L (no) 1988-12-15 1989-12-14 Hurtig avspaltbart substrat for hiv-protease.

Country Status (16)

Country Link
US (1) US5093477A (no)
EP (1) EP0373576B1 (no)
JP (1) JPH02207097A (no)
KR (1) KR900009694A (no)
AT (1) ATE120205T1 (no)
AU (1) AU4614889A (no)
CA (1) CA2005516A1 (no)
DE (2) DE3842197A1 (no)
DK (1) DK634389A (no)
ES (1) ES2070886T3 (no)
FI (1) FI895950A0 (no)
GR (1) GR3015740T3 (no)
IL (1) IL92687A0 (no)
NO (1) NO895027L (no)
PT (1) PT92574A (no)
ZA (1) ZA899556B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428000A1 (en) * 1989-11-03 1991-05-22 Abbott Laboratories Fluorogenic substrates for the detection of proteolytic enzyme activity
US5235039A (en) * 1991-06-10 1993-08-10 Eli Lilly And Company Substrates for hiv protease
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
RU2126794C1 (ru) * 1992-03-11 1999-02-27 Нархекс Лимитед Аминопроизводные оксо- или гидроксизамещенных гидразинов, способ их получения и фармацевтические композиции для ингибирования ретровирусной протеазы
DE69333270T2 (de) 1992-03-11 2004-08-05 Narhex Ltd. Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US5965532A (en) * 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6100234A (en) * 1997-05-07 2000-08-08 Tufts University Treatment of HIV
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
ES2285785T3 (es) 1997-09-29 2007-11-16 Point Therapeutics, Inc. Estimulacion de celulas hematopoyeticas in vitro.
MY132924A (en) * 1998-05-04 2007-10-31 Point Therapeutics Inc Hematopoietic stimulation
WO1999062914A1 (en) 1998-06-05 1999-12-09 Point Therapeutics, Inc. Cyclic boroproline compounds
US6979697B1 (en) * 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
US20060014697A1 (en) * 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
AU2003248921A1 (en) * 2002-07-09 2004-01-23 Point Therapeutics, Inc. Boroproline compound combination therapy
US20060063719A1 (en) * 2004-09-21 2006-03-23 Point Therapeutics, Inc. Methods for treating diabetes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293591C (en) * 1985-01-11 1991-12-24 Charles A. Kettner Peptide substrates for detecting virus-specified protease activity
DE3643012A1 (de) * 1986-12-17 1988-06-30 Hoechst Ag 2,3-disubstituierte isoxazolidine, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
DE3736589A1 (de) * 1987-10-29 1989-05-11 Behringwerke Ag Glutaminhaltige peptide, verfahren zu deren herstellung und verwendung
US5011910A (en) * 1989-12-28 1991-04-30 Washington University Reagent and method for determining activity of retroviral protease

Also Published As

Publication number Publication date
PT92574A (pt) 1990-06-29
DK634389A (da) 1990-06-16
DE58909130D1 (de) 1995-04-27
DK634389D0 (da) 1989-12-14
NO895027L (no) 1990-06-18
GR3015740T3 (en) 1995-07-31
KR900009694A (ko) 1990-07-05
ZA899556B (en) 1990-09-26
IL92687A0 (en) 1990-09-17
ES2070886T3 (es) 1995-06-16
JPH02207097A (ja) 1990-08-16
EP0373576A3 (en) 1990-10-31
DE3842197A1 (de) 1990-06-21
US5093477A (en) 1992-03-03
ATE120205T1 (de) 1995-04-15
FI895950A0 (fi) 1989-12-13
CA2005516A1 (en) 1990-06-15
EP0373576B1 (de) 1995-03-22
EP0373576A2 (de) 1990-06-20
AU4614889A (en) 1990-06-21

Similar Documents

Publication Publication Date Title
NO895027L (no) Hurtig avspaltbart substrat for hiv-protease.
ATE108438T1 (de) Urethan geschützte aminosäuren-n- carboxyanhydride.
NO882472L (no) Fremgangsmaate for fremstilling av peptidborsyreinhibitorer for trypsinlignende proteaser.
GB1488987A (en) Chromogenic enzyme substrates
DK135887D0 (da) Human-vaevstype-plasminogenaktivator-polypeptider og fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK0387231T3 (da) Hidtil ukendte inhibitorer for retroviral protease
ES2044950T3 (es) Un procedimiento para producir una proteina.
ZA899559B (en) Use of peptide isosteres as retroviral protease inhibitors
DK0495918T3 (da) Aminosyre-beta-lyaseenzyminhibitorer som deodoranter
DK627488A (da) Fremgangsmaade til fremstilling af bionedbrydelige mikrokapsler af vandoploeselige peptider og proteiner samt ved denne fremgangsmaade opnaaede mikrokapsler
ES2118939T3 (es) Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi.
ATE154036T1 (de) Retrovirale protease-inhibitoren
NO892994L (no) Toeyvaskemiddelblanding og fremgangsmaate for fremstilling av denne.
IL102615A (en) Immunoassy kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-ii and methods for te detections of antibodies
DE3751398D1 (de) Substrat-Peptide.
US6159746A (en) Solid phase immunoassay to detect inhibitors of proteolytic enzymes
DE68904315D1 (de) Peptide-hemmer von phospholipase a2.
ATE46173T1 (de) Pharmakologisch aktive peptide.
DK362288D0 (da) Homocyclostatin- og cyclostatinholdige peptider og farmaceutiske praeparater indeholdende disse
DK185087D0 (da) Kromofore peptider, deres fremstilling og anvendelse til paavisning af den peptidylglycin-alfa-amiderende monooxygenase, samt ved fremstillingen anvendelige mellemprodukter
TH13932EX (th) "การตรวจภูมิคุ้มกันสำหรับการค้นหาพร้อมๆ กันของแอนตี้บอดี้เอชไอวี-1, เอชไอวี-2, เอชทีแอลวี-i และเอชทีแอลวี-ii"
TW370615B (en) Method and kit for simultaneously detecting antibodies of HIV-1 and HIV-2